CD8A and cancer: We further detected the CD4+ IFNAR1 levels and CD8+ PD1 levels of peripheral blood lymphocytes in 15 patients with VPS9D1-AS1 positive expression and 16 patients with VPS9D1-AS1 negative expression in cancer tissues (Figure 5D-E).